跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Prazosave
Approved
STANDARD
Prazosave
Gufic Biosciences Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fba2d27f6d97e867
Company
Gufic Biosciences Limited
Type
Standard
Approval Details
Approval Id
fba2d27f6d97e867
Drug Approval Philippines Name
Prazosave
Product Name
Prazosave
Registration Number
DRP-5896-04
Brand Name
Prazosave
Generic Name
Pantoprazole (as Sodium sesquihydrate)
Dosage Form
Lyophilized Powder For Injection (IV)
Dosage Strength
40 mg
Manufacturer
Gufic Biosciences Limited
Trader
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Curasave Pharma
Company Detail Path
/organization/gufic-biosciences-limited
Issuance Date
16 May 2024
Expiry Date
15 December 2029
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fba2d27f6d97e867
Type
Standard
Back to Philippines FDA Approvals
Prazosave - Philippines FDA Drug Approval Details